The Cardioprotective Effect of Vitamin D in Breast Cancer Patients Receiving Adjuvant Doxorubicin Based Chemotherapy.

El-Bassiouny, Noha A; Helmy, Maged W; Hassan, Mostafa Alaa Eldin; Khedr, Gehan A

El-Bassiouny, Noha A; Helmy, Maged W; Hassan, Mostafa Alaa Eldin; Khedr, Gehan A.

Afiliación

El-Bassiouny NA; Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Damanhour University, Egypt. Electronic address: noha.el.bassiouny@pharm.dmu.edu.eg.
Helmy MW; Department of Pharmacology and toxicology, Faculty of Pharmacy, Damanhour University, Egypt.
Hassan MAE; Bachelor of Pharmaceutical Sciences, Faculty of Pharmacy, University of Alexandria, Alexandria, Egypt.
Khedr GA; Department of Clinical Oncology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.

Clin Breast Cancer ; 22(4): 359-366, 2022 06.

Article en En | MEDLINE | ID: mdl-35241369

Asunto(s)

Neoplasias de la Mama; Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos; Neoplasias de la Mama/tratamiento farmacológico; Neoplasias de la Mama/etiología; Quimioterapia Adyuvante/efectos adversos; Ciclofosfamida/efectos adversos; Doxorrubicina; Femenino; Humanos; Interleucina-6/uso terapéutico; Vitamina D/uso terapéutico; Vitaminas

Palabras clave

Breast cancer; Cardio toxicity; Doxorubicin; Vitamin D

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Etiology_studies Límite: Female / Humans Idioma: En Revista: Clin Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google